Anti-tumor activity of the small molecule inhibitor PRI-724 against β-catenin-activated hepatocellular carcinoma

PRISM BioLab > News > Anti-tumor activity of the small molecule inhibitor PRI-724 against β-catenin-activated hepatocellular carcinoma

    PRISM is open to all levels of scientific discussion. Our scientists would love to speak with you!

    Scroll to top
    en_USEnglish
    jaJapanese en_USEnglish